In addition to focusing on HTT palmitoylation, a potential risk factor controlling the S-palmitoylation of TRPC5 channels could modulate TRPC5 channel expression and activity, providing new insights into novel therapeutic strategies for HD (Hong et al., 2020). Here, TRPC5 is linked to Huntington disease.